Cargando…
A compound attributes-based predictive model for drug induced liver injury in humans
Drug induced liver injury (DILI) is one of the key safety concerns in drug development. To assess the likelihood of drug candidates with potential adverse reactions of liver, we propose a compound attributes-based approach to predicting hepatobiliary disorders that are routinely reported to US Food...
Autores principales: | Liu, Yang, Gao, Hua, He, Yudong D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159228/ https://www.ncbi.nlm.nih.gov/pubmed/32294131 http://dx.doi.org/10.1371/journal.pone.0231252 |
Ejemplares similares
-
Drug Induced Liver Injury Attributed to a Curcumin Supplement
por: Imam, Zaid, et al.
Publicado: (2019) -
Applications of In Silico Models to Predict Drug-Induced Liver Injury
por: Lin, Jiaying, et al.
Publicado: (2022) -
Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
por: Wu, Xiaoshan, et al.
Publicado: (2023) -
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man
por: Dragovic, Sanja, et al.
Publicado: (2016) -
Human liver chimeric mouse model based on diphtheria toxin-induced liver injury
por: Ren, Xiao-Nan, et al.
Publicado: (2017)